Published in Semin Intervent Radiol on December 01, 2005
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology (1995) 2.47
Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol (2004) 2.21
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med (2000) 2.20
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology (2002) 2.12
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
TIPSS 10 years on. Gut (2000) 1.48
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology (1997) 1.29
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol (2001) 1.15
Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg (2001) 1.12
Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology (1998) 1.11
Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology (1993) 1.05
Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol (2004) 1.01
Transcaval TIPS: indications and anatomic considerations. J Vasc Interv Radiol (1999) 0.97
Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol (1998) 0.97
Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology (1995) 0.96
Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol (1997) 0.95
Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach. Cardiovasc Intervent Radiol (1996) 0.93
Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol (1996) 0.92
Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. Cardiovasc Intervent Radiol (1995) 0.90
Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements. J Vasc Interv Radiol (2003) 0.89
Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee. J Vasc Interv Radiol (2001) 0.87
Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol (2002) 0.85
Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol (2002) 0.82
Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center. Acta Radiol (2000) 0.82
Transjugular intrahepatic portosystemic shunts through hepatic neoplasms. J Vasc Interv Radiol (2003) 0.81
Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol (1996) 0.81
Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein. J Vasc Interv Radiol (1999) 0.79
Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer (2004) 0.79
Stent-graft for TIPS in a hepatocellular carcinoma patient with main portal vein invasion. AJR Am J Roentgenol (2004) 0.78
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J (2003) 2.02
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer (2005) 1.67
Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis Sci (2010) 1.44
Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery (2008) 1.41
Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol (2013) 1.40
Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol (2007) 1.31
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg (2007) 1.25
Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg (2007) 1.21
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol (2005) 1.18
Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol (2007) 1.13
Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol (2003) 1.11
Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications. Radiology (2005) 1.11
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery (2009) 1.07
Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics (2005) 1.06
Re: portal vein embolization: what do we know? Cardiovasc Intervent Radiol (2012) 1.05
Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol (2008) 1.05
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol (2005) 1.02
Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol (2005) 1.00
Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol (2008) 0.97
Handheld histology-equivalent sectioning laser-scanning confocal optical microscope for interventional imaging. Biomed Microdevices (2010) 0.96
Preoperative portal vein embolization: an approach to improve the safety of major hepatic resection. Semin Roentgenol (2011) 0.96
Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol (2008) 0.96
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer (2006) 0.95
Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations. Radiographics (2004) 0.93
Fistulas of the lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics (2004) 0.90
Percutaneous portal vein access and transhepatic tract hemostasis. Semin Intervent Radiol (2012) 0.90
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol (2008) 0.90
Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther (2014) 0.89
Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol (2009) 0.89
Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and relevant anatomic and technical considerations. Radiographics (2007) 0.89
Image-guided percutaneous needle biopsy in cancer diagnosis and staging. Tech Vasc Interv Radiol (2007) 0.88
Use of inferior vena caval filters and survival in patients with malignancy. Cancer (2004) 0.88
Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol (2007) 0.88
Portal vein embolization in hilar cholangiocarcinoma. Surg Oncol Clin N Am (2009) 0.88
Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol (2007) 0.87
Development of a large animal model for lung tumors. J Vasc Interv Radiol (2002) 0.86
Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol (2003) 0.86
Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity. Mol Cancer Ther (2011) 0.86
Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J Vasc Interv Radiol (2013) 0.85
Acute endovascular stent-graft occlusion after treatment of an arterioureteral fistula. J Vasc Interv Radiol (2005) 0.85
Superior mesenteric artery pseudoaneurysm following pancreaticoduodenectomy: management by endovascular stent-graft placement and transluminal thrombin injection. Cardiovasc Intervent Radiol (2007) 0.85
Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: a study in swine. J Vasc Interv Radiol (2011) 0.85
Portal vein embolization: rationale, outcomes, controversies and future directions. Expert Rev Gastroenterol Hepatol (2010) 0.84
Using a coaxial technique with a curved inner needle for CT-guided fine-needle aspiration biopsy. AJR Am J Roentgenol (2002) 0.84
Acute Thrombosis of Left Portal Vein during Right Portal Vein Embolization Extended to Segment 4. Semin Intervent Radiol (2011) 0.84
Outpatient management of postbiopsy pneumothorax with small-caliber chest tubes: factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol (2007) 0.83
Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol (2010) 0.83
Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl (2014) 0.82
Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg Oncol Clin N Am (2002) 0.82
Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol (2012) 0.82
Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer (2007) 0.82
Percutaneous extraction of retained biliary T-tubes: a new technique. J Vasc Interv Radiol (2005) 0.81
Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol (2003) 0.81
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol (2007) 0.81
Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol (2008) 0.80
Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer (2010) 0.80
Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. J Magn Reson Imaging (2013) 0.79
CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol (2010) 0.79
Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer (2004) 0.79
Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest (2011) 0.79
Liver anatomy: microcirculation of the liver. Semin Intervent Radiol (2008) 0.78
Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol (2004) 0.78
Chemoembolization of the liver after portal vein embolization: report of three cases. J Vasc Interv Radiol (2008) 0.78
Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients. Acta Radiol (2013) 0.76
Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr (2004) 0.75
Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases. Clin Colorectal Cancer (2010) 0.75
What's New in Transarterial Therapies for Hepatocellular Carcinoma? Gastrointest Cancer Res (2012) 0.75
Transbronchial treatment of a bleeding pulmonary mycetoma refractory to arterial embolization. J Vasc Interv Radiol (2013) 0.75
Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol (2009) 0.75
CT-guided needle biopsy of deep pelvic lesions by extraperitoneal approach through iliopsoas muscle. Cardiovasc Intervent Radiol (2004) 0.75
Interventional radiology in the multidisciplinary management of liver lesions: pre- and postoperative roles. Semin Liver Dis (2013) 0.75
Embolization for multicompartmental bleeding in patients in hemodynamically unstable condition: prognostic factors and outcome. J Vasc Interv Radiol (2012) 0.75